Zevra Therapeutics Inc (ZVRA)

Cost of Revenue

$6.86M

TTM · Period ending: · USD

ZVRA logo

ZVRA Cost of Revenue

Latest reported$6.86M
ZVRA TTM Cost of Revenue ($0.00 → $6.86M)
High-resolution chart · PNG

ZVRA cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Zevra Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
6,863,000
17,717,000
16,797,000
16,643,000
17,393,000
8,587,000
10,507,000
11,927,000
9,768,000
6,872,000
3,732,000
1,089,000
1,086,000
460,000
343,000
259,000
118,000
1,067,000
2,059,000
2,000,000
2,000,000
1,642,000
1,305,000
3,250,000
4,250,000
3,608,000
2,945,000
1,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.